Home‎ > ‎

ASCO Research Abstract News = No News

posted May 19, 2011, 4:23 PM by Bryce Istvan
As previously discussed Wednesday night was the release of research abstracts for the clinical trials that are due to be presented at the American Society for Clinical Oncology's annual meeting June 3rd-7th. Little new information about any of the drugs being presented was released in the abstracts and because of that little movement occurred in the stocks of any of the companies presenting. The biggest movers were to the downside with Oxigene (OXGN) falling about 8%. This move was likely due to a "sell the news" strategy as nothing really new was presented in the abstract. A full article covering the abstract can be found from Adam Feuerstein of TheStreet.com here http://www.thestreet.com/story/11125771/1/asco-thursdays-cancer-stock-winners-losers.html

The abstracts can be accessed from ASCO's website www.asco.org